Table 2 Immunizations administered after epilepsy diagnosis
From: Risk of seizures after immunization in children with epilepsy: a risk interval analysis
N | % | |
|---|---|---|
Number of immunization visits per subject (N = 80) | ||
1 | 45 | 31 |
≥ 2 | 35 | 24 |
Vaccine type(s) administered at immunization visits (N = 161) | ||
Inactivated vaccine(s) only | 94 | 58 |
Live vaccine(s) only | 7 | 4 |
Live and inactivated vaccines co-administered | 60 | 37 |
DTaP | 76 | 47 |
Influenza | 27 | 17 |
MenC | 7 | 4 |
MMR/MMRV | 22 | 14 |
PCV | 16 | 10 |
Rotavirus | 3 | 2 |
Varicella | 5 | 3 |
Other | 5 | 3 |
Age at immunization event (N = 161) | ||
0–11 months | 39 | 24 |
12–23 months | 47 | 29 |
24–47 months | 21 | 13 |
48–83 months | 54 | 34 |
Season of immunization (N = 161) | ||
Winter | 30 | 19 |
Spring | 30 | 19 |
Summer | 56 | 35 |
Fall | 45 | 28 |